FDA Approves MedApps Wireless Remote Monitoring

The wireless remote monitoring system, HealthPAL, which MedApss developed, has received 510(k) clearance from the FDA.

The wireless remote monitoring system, HealthPAL, which MedApss developed, has received 510(k) clearance from the FDA.

HealthPAL is the small, portable dedicated device that MedApps uses to collect data from connected glucose meters, blood pressure monitors, pulse oximeters and weight scales. The data is then sent over a secure server to an online portal like Microsoft’s HealthVault or Google Health for caregivers, physicians or the patient themselves to view.

MedApps has conducted pilots at Cleveland Clinic and Baptist Home Health Network to test the system.

The HealthPAL device is about the size of a cell-phone and its low cost enables remote monitoring to be available to large patient populations. While it has some buttons for special features and set-up, the reading and data transmissions are automated, the patient does not push any buttons, navigate any screen commands or touch the HealthPAL in any fashion.

“Our entire system is designed around a single criterion - increasing patient compliance,” Kent Dicks, MedApps founder and CEO explains. “Patient compliance is greatly dependent on simplicity, and simplicity helps drive costs down and reliability up. It’s key in keeping patients engaged and healthcare costs in check, and its no coincidence that we have significantly improved patient compliance in all of our pilots.”

medapps.net